The size of the global continuous positive airway pressure (CPAP) devices market in 2024 was USD 1.90 billion and is anticipated to progress at a CAGR of 5.45% during the forecast period 2025-2030.  The rise in the incidence of sleep apnea, the rise in the focus on preventive healthcare, and the fast development of the healthcare infrastructure in the emerging economies. The increasing supportive efforts of government and private entities for Continuous Positive Airway Pressure (CPAP) machines is a strong trend anticipated to drive market growth.

In addition, growth in the demand for home-based healthcare solutions and remote monitoring options are driving market growth. With healthcare systems transitionally converting care delivery from hospitals to home, there is increased demand for the use of sleep apnea devices for home-based noninvasive ventilation therapy. CPAP machines provide an affordable and convenient option to hospital-based treatment, enabling patients to receive respiratory therapy at home. Home care environments enable patients to utilize CPAP devices in the comfort of familiar surroundings, promoting comfort and compliance with therapy. This is especially important for patients who need long-term treatment of sleep apnea, as the device can be incorporated into daily routine without the hassle of visiting hospitals.

Public health departments in government and charities frequently organize public education campaigns to inform the public on sleep apnea and why it should be treated. For example, in America, the CDC has incorporated sleep apnea into its general public health communications regarding sleep hygiene and the management of chronic disease. Likewise, in the UK, the National Health Service (NHS) supports awareness for sleep health and urges individuals to undergo diagnostic testing for sleep apnea. Moreover, World Sleep Day, initiated by the World Sleep Society, is a yearly international event intended to raise awareness of sleep disorders such as sleep apnea. The event commands extensive media coverage and endorsement from healthcare societies, adding momentum to the adoption of CPAP therapy.

Market Consantration & Characteristics

The following diagram explains the connection between industry concentration, industry characteristics, and industry players. The x-axis shows the extent of industry concentration from low to high. The y-axis shows different industry characteristics such as impact of regulations, degree of innovation, industry competition, regional expansion, and level of partnerships & collaborations activities. The CPAP devices market is concentrated with the existence of few providers controlling the market. The level of partnerships & collaborations activities is moderate, and the level of innovation is high. The level of regional expansion is low, and the industry's impact of regulations is high.

The innovation level in the industry is high. The demand for effective and easier-to-use solutions for sleep apnea treatment is increasing. Technological innovations are the key factor, with firms continually looking to increase device performance and patient comfort. Additionally, huge investments in research and development are likely to propel market growth. For example, React Health introduced the Luna TravelPAP, a compact and light portable travel-positive airway pressure device, in March 2024. The product has a pressure range of 4-20 hPA, a 0-60 minutes ramp time, and a sound level of less than 30 dBA.

Partnerships & collaborations within the industry are of moderate level. The reason is the niche nature of the market, in which each company has distinctive technologies. Although these partnerships are pivotal to product and geographic expansion, competitive factors and intellectual property issues on occasion cap the level of cooperation. In September 2023, for example, Nyxoah SA, a medtech company, entered into an agreement with ResMed Germany to increase OSA therapy penetration and consciousness in Germany.

The regulatory impact on the market is high because of the high standards of safety and efficacy needed for approval of medical devices. The regulations guarantee patient safety, but at the same time, they add to the time and expense of putting new devices on the market.

The extent of regional growth in the industry is low owing to strict regulatory hurdles in various regions, a wide gap between advanced and developing nations in terms of healthcare infrastructure, the high cost involved in cutting-edge CPAP devices technology, and insufficient reimbursement policies further limit market growth in poor regions. 

Connectivity Insights

The attached CPAP devices segment accounted for more than 68.00% of the revenue share in 2024 and is forecast to grow at the highest growth rate during the forecast period. This growth in this segment is attributed to the revolution in sleep apnea management with higher technology integration towards real-time monitoring and individualized care, promoting user compliance and efficacy. The growth in this segment is being driven by innovations in technology, growing prevalence of sleep apnea, and increased aging population, and products such as ResMed's AirSense 10 and 11 driving the segment with enhanced connectivity and mobile health capabilities.

The unconnected device segment is expected to register a strong CAGR during the forecast period. This is because they are simple, inexpensive, and easy to use, particularly among technology-resistant users and individuals in need of instant, uncomplicated sleep apnea relief. They are affordable and easy to use, which is appealing to cost-sensitive users and individuals who have limited access to the internet and prioritize ease of use over sophisticated connectivity features.